Clenbuterol antibody

Catalog No. ABIN1385072

Product Details

Target: Clenbuterol

Reactivity: Please inquire

Host: Rabbit

Clonality: Polyclonal

Conjugate: Un-conjugated

Application: ELISA, Flow Cytometry (FACS)

Cross-Reactivity (Details): Clenbuterol

Purification: Purified by Protein A.

Immunogen: Clenbuterol conjugated to KLH

Isotype: IgG

Application Details

Application Notes: ELISA 1:500-1000

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Expiry Date: 12 months

References

Yao, Wu, Fang, Yang, Liu: "Spectral surface plasmon resonance imaging for the detection of clenbuterol via three-dimensional immobilization of bioprobes." in: Analytical biochemistry, Vol. 475, pp. 40-3, (2015) (PubMed).

Wu, Yao, Fang, Yang, Cheng: "Clenbuterol Assay by Spectral Imaging Surface Plasmon Resonance Biosensor System." in: Applied biochemistry and biotechnology, Vol. 177, Issue 6, pp. 1327-37, (2015) (PubMed).

Target Details

Target: Clenbuterol

Target Type: Chemical

Background:

Synonyms: 1 4 amino 3 5 dichloro phenyl 2 tert butylaminoethanol, Spiropent, Clenbuterol.

Background: Clenbuterol belongs to the group of agonists. In livestock production clenbuterol improves the meat/fat ratio in fattened animals or accelerate the growth. Up to now agonists have not been authorized as adjuvants for fattening. In addition to its lipolytic and anabolic effect, clenbuterol has a relaxing effect on non-striated musculature on which is based its therapeutic use as an antiasthmatic and a tocolytic agent. Clenbuterol is a long acting beta 2 adrenergic agonist. Like other beta 2 agonists, clenbuterol is believed to act by stimulating production of cyclic AMP through the activation of adenyl cyclase. By definition, Beta 2 agonists have more smooth muscle relaxation activity (bronchial, vascular and uterine smooth muscle) versus its cardiac effects (Beta 1).